Tables and Figures
Table 1 Characteristics of the randomized controlled trials for the treatment of COVID-19 with hydroxychloroquine or chloroquine (n=51).
Table 2 Fixed dosing administration schedules described in randomized controlled trials planning to assess the effects of hydroxychloroquine or chloroquine in the treatment of COVID-19 (n=19).
Table 3 Variable dosing administration schedules described in randomized controlled trials planning to assess the effects of hydroxychloroquine or chloroquine in the treatment of COVID-19 (n=20).
Table 4 Efficacy and safety outcomes described in randomized controlled trials planning to assess the effects of hydroxychloroquine or chloroquine in the treatment of COVID-19 (n=51).
Figure 1 Flow diagram illustrating the selection of the clinical trial registers available on the
the International Clinical Trials Registry Platform(ICTRP)onApril8 ,2020at10:30GMT-6
Figure 2 Efficacy outcomes among randomized controlled trials of hydroxychloroquine or chloroquine for the treatment of COVID-19.
Figure 3 Safety outcomes among randomized controlled trials of hydroxychloroquine or chloroquine for the treatment of COVID-19.
Supplementary material